tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymphoma, mantle-cell - daganatellenes szerek - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
sustac mite 2,6 mg retard tabletta
krka d.d., - gliceril trinitrate -
sustac forte 6,4 mg retard tabletta
krka d.d., - gliceril trinitrate -
paniverin tabletta
sanofi-aventis zrt. - a nikotinsav; drotaverine -
berotec n 100 mikrogramm/adag túlnyomásos inhalációs oldat
boehringer ingelheim international gmbh - fenoterol -
glucoplasmal 3,5% infúzió, 1000 ml
b. braun melsungen ag - aminosavak; glükóz -
pädamin infúzió, 250 ml
fresenius kabi ag - aminosavak -
vamin 14 elektrolyte-free infúzió
fresenius kabi ag - aminosavak -
vamin 14 infúzió
fresenius kabi ag - aminosavak -
vamin 18 elektrolyte-free infúzió
fresenius kabi ag - aminosavak -